A new law quietly went into effect in January that requires health insurers to cover the cost of routine screening for prostate cancer, a measure aimed at encouraging more men to consider the benefits of being tested.
New York is the only state in the country to pass a law that supports full insurance coverage of the PSA (prostate-specific antigen) blood test, which helps determine prostate cancer risk.
The new law is the brainchild of a coalition of New York urologists and patient advocacy organizations that not only saw a need for the legislation, but over a two-year period made a case for the measure among legislators in Albany.
